Certus Molecular Diagnostics

Certus Molecular Diagnostics Overview

  • Founded
  • 2017
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $111K
Latest Deal Amount
  • Investors
  • 1

Certus Molecular Diagnostics General Information


Provider of novel molecular diagnostics intended to detect specific microorganisms and diseases. The company's diagnostic method isoAMP is a reliable method for on-site detection of pathogens such as herpes or influenza viruses at their early stages, enabling healthcare providers to immediately diagnose diseases and carry out pathogen-specific therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • Schloss Reichenbach 9
  • Zollikofen
  • 3052 Bern
  • Switzerland
+41 031 000 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Certus Molecular Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 18-May-2017 $111K Completed Startup

Certus Molecular Diagnostics Executive Team (2)

Name Title Board Seat Contact Info
Alexander Lüthi Co-Founder
Samuel Zürcher Co-Founder

Certus Molecular Diagnostics Investors (1)

To view Certus Molecular Diagnostics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Venture Kick Accelerator/Incubator 000 0000 000000 0

Ready to get started?

Request a free trial